Clinical Trial Update: Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating nivolumab with or without ipilimumab, plus radiation therapy, in patients with recurrent or resectable dedifferentia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING